查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1655419

全球神经血管支架市场

Neurovascular Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球神经血管支架市场将达到 34 亿美元

2024 年全球神经血管支架市场规模估计为 19 亿美元，预计 2030 年将达到 34 亿美元，2024 年至 2030 年的复合年增长率为 9.7%。颈动脉支架是报告中分析的细分市场，预计其复合年增长率为 10.3%，到分析期结束时市场规模将达到 25 亿美元。预计分析期内颅内支架段的复合年增长率为 8.0%。

美国市场规模估计为 5.487 亿美元，中国市场预期复合年增长率为 9.0%

预计2024年美国神经血管支架市值将达5.487亿美元。作为世界第二大经济体的中国，预计到 2030 年市场规模将达到 5.115 亿美元，2024-2030 年分析期间的复合年增长率为 9.0%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 8.7% 和 7.8%。在欧洲，预计德国的复合年增长率约为 7.7%。

全球神经血管支架市场 - 主要趋势与驱动因素摘要

什么是神经血管支架？

神经血管支架是用于治疗脑血管疾病的专用装置，特别是用于预防和治疗缺血性中风和动脉瘤。这些微小的网状管被放置在脑血管内，以保持动脉畅通或将血流从动脉瘤转移出去。在缺血性中风的情况下，血栓会阻塞流向大脑的血液，通常使用神经血管支架来恢復血流并防止永久性脑损伤。对于动脉瘤来说，分流支架可以有效地将血液引导出薄弱的血管壁，从而降低破裂的风险。

神经血管支架极为重要，因为它们可以对需要更具侵入性和风险的手术治疗的疾病进行微创治疗。支架在手术过程中和手术后支撑动脉壁并防止其崩坏的能力对于其有效性至关重要。这些支架的使用正在彻底改变中风管理，改善患者的治疗效果，缩短恢復时间，并显着降低中风復发和动脉瘤破裂的风险。

神经血管支架市场进展如何？

由于更复杂和专业的支架设计的发展，神经血管支架市场正在快速发展。一个重要的趋势是血流分流支架的兴起，其在治疗复杂的宽颈部动脉瘤方面变得越来越普遍。与传统支架不同，血流分流器的工作原理是将血流从动脉瘤转移出去，使血管随着时间的推移而癒合。这项创新减少了多次手术的需要，并为曾经被认为无法手术的动脉瘤提供了更安全的选择。

另一项重大进步是自动扩张型支架的发展。此支架的设计是为了适应患者血管的独特形状。这些支架可以更精确地部署，并且不太可能对动脉造成创伤。此外，生物可吸收支架越来越受欢迎，这种支架在达到其作用后会逐渐溶解。这些支架降低了与永久植入相关的长期风险，对于年轻患者和因传统金属支架而面临併发症风险较高的患者尤其有益。

哪些疾病推动了神经血管支架的采用？

神经血管支架的采用主要是为了治疗缺血性中风和脑动脉瘤。在缺血性中风中，当血栓阻塞流向大脑的血液时，血栓摘取支架对于恢復血流和防止长期残疾或死亡至关重要。这些装置可以机械地去除血栓并重新打开阻塞的动脉，显着改善患者的治疗效果。神经血管支架也用于治疗颈动脉狭窄。颈动脉狭窄是一种颈动脉变窄的疾病，会限制流向大脑的血液并增加中风的风险。

脑动脉瘤是推动支架应用的另一个重要疾病。流量转移支架用于治疗传统栓塞技术难以治疗的宽颈或大型动脉瘤。这些支架提供了一种微创解决方案，可降低动脉瘤破裂的风险并使血管随着时间的推移而癒合。此外，神经血管支架也用于治疗动静脉畸形（AVM）等血管畸形，进一步扩大其在神经病学的应用。

推动神经血管支架市场成长的关键因素有哪些？

神经血管支架市场的成长受到多种因素的推动。缺血性中风和脑动脉瘤发生率的不断增加，尤其是在老化人口中，是需求的主要驱动力。此外，人们对微创治疗的日益偏好推动了神经血管支架的采用，因为它们比传统手术提供了更安全、更快速、更有效的治疗选择。支架设计中的技术创新，例如流量转移技术和生物可吸收材料，也透过提高这些设备的安全性和有效性推动了市场成长。

人们对中风预防和早期疗育益处的认识不断提高，加上政府采取措施降低中风相关死亡率，进一步推动了市场的发展。此外，医学影像和即时导航技术的进步正在提高神经血管支架手术的精确度并改善患者的治疗效果。新兴市场的医疗保健基础设施不断扩大，也透过增加获得先进神经血管治疗的机会促进了市场的成长。

部分

产品类型（颈动脉支架、颅内支架）、最终用户（医院、门诊手术中心）

受访公司范例（值得关注的11家公司）

  • Abbott Laboratories
  • ACANDIS GmbH
  • Blockade Medical LLC
  • Cordis Corporation
  • InspireMD, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • STI Laser Industries, Ltd.
  • Stryker Corporation
  • Terumo Medical Corporation
  • WL Gore & Associates

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP13585

Global Neurovascular Stents Market to Reach US$3.4 Billion by 2030

The global market for Neurovascular Stents estimated at US$1.9 Billion in the year 2024, is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 9.7% over the analysis period 2024-2030. Carotid Artery Stents, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Intracranial Stents segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$548.7 Million While China is Forecast to Grow at 9.0% CAGR

The Neurovascular Stents market in the U.S. is estimated at US$548.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$511.5 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.7% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Global Neurovascular Stents Market - Key Trends & Drivers Summarized

What Are Neurovascular Stents and Why Are They Crucial in Stroke Management?

Neurovascular stents are specialized devices used to treat cerebrovascular conditions, particularly in the prevention and treatment of ischemic strokes and aneurysms. These small, mesh-like tubes are implanted in blood vessels in the brain to help keep arteries open or to redirect blood flow away from aneurysms. In cases of ischemic stroke, where blood clots block the flow of blood to the brain, neurovascular stents are often deployed to restore circulation and prevent permanent brain damage. For aneurysms, flow-diverting stents offer an effective way to redirect blood away from weakened vessel walls, reducing the risk of rupture.

Neurovascular stents are vital because they enable minimally invasive treatments for conditions that would otherwise require more invasive and higher-risk procedures. Their ability to support the artery walls and prevent collapse during and after the procedure is critical to their effectiveness. The use of these stents has revolutionized stroke management by improving patient outcomes, reducing recovery times, and significantly decreasing the risk of recurrent strokes or aneurysm ruptures.

How Is the Neurovascular Stents Market Advancing?

The neurovascular stents market is advancing quickly due to the development of more sophisticated and specialized stent designs. One of the key trends is the rise of flow-diverting stents, which are becoming increasingly popular for treating complex and wide-necked aneurysms. Unlike traditional stents, flow-diverters work by diverting blood flow away from the aneurysm, allowing the vessel to heal over time. This innovation reduces the need for multiple procedures and offers a safer alternative for aneurysms that were once considered inoperable.

Another significant advancement is in the development of self-expanding stents, which are designed to conform to the unique shape of the patient’s blood vessel. These stents can be deployed with greater precision and are less likely to cause trauma to the artery. Moreover, bioresorbable stents, which gradually dissolve after serving their purpose, are gaining traction. These stents reduce the long-term risks associated with permanent implants and are particularly beneficial in younger patients or those at higher risk for complications from traditional metal stents.

Which Conditions Are Driving the Adoption of Neurovascular Stents?

The adoption of neurovascular stents is primarily driven by the need to treat ischemic strokes and brain aneurysms. In ischemic strokes, where a blood clot obstructs blood flow to the brain, stent retrievers are critical in restoring circulation and preventing long-term disability or death. These devices allow for the mechanical removal of the clot and the reopening of the blocked artery, significantly improving patient outcomes. Neurovascular stents are also used in the treatment of carotid artery stenosis, a condition in which the carotid arteries narrow and restrict blood flow to the brain, increasing stroke risk.

Brain aneurysms are another key condition driving stent adoption. Flow-diverting stents are used to treat wide-necked or large aneurysms that are difficult to treat with traditional coiling techniques. These stents offer a minimally invasive solution that reduces the risk of aneurysm rupture and allows for vessel healing over time. Additionally, neurovascular stents are being used in treating vascular malformations such as arteriovenous malformations (AVMs), further expanding their applications in neurology.

What Are the Key Growth Drivers in the Neurovascular Stents Market?

The growth in the neurovascular stents market is driven by several factors. The increasing incidence of ischemic strokes and brain aneurysms, particularly among aging populations, is a primary driver of demand. Additionally, the growing preference for minimally invasive procedures is pushing the adoption of neurovascular stents, as they offer safer, faster, and more effective treatment options than traditional surgery. Technological innovations in stent design, such as flow-diversion technology and bioresorbable materials, are also fueling market growth by improving the safety and efficacy of these devices.

The rising awareness of stroke prevention and the benefits of early intervention, along with government initiatives to reduce stroke-related mortality, are further boosting the market. Moreover, advances in medical imaging and real-time navigation technologies are making neurovascular stent procedures more precise, enhancing patient outcomes. Expanding healthcare infrastructure in developing regions is also contributing to market growth by increasing access to advanced neurovascular treatments.

SCOPE OF STUDY:

The report analyzes the Neurovascular Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Carotid Artery Stents, Intracranial Stents); End-Use (Hospitals, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • Abbott Laboratories
  • ACANDIS GmbH
  • Blockade Medical LLC
  • Cordis Corporation
  • InspireMD, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • STI Laser Industries, Ltd.
  • Stryker Corporation
  • Terumo Medical Corporation
  • W. L. Gore & Associates

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Neurovascular Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Stroke and Aneurysms Drives Demand for Neurovascular Stents in Minimally Invasive Treatments
    • Advancements in Stent Technology Propel Growth in Neurovascular Stents for Aneurysm Coiling and Clot Removal
    • Increasing Adoption of Flow Diversion Stents Expands Market for Aneurysm Management in Interventional Neurology
    • Growing Preference for Minimally Invasive Procedures Strengthens Demand for Neurovascular Stents in Stroke Treatment
    • Technological Innovations in Retrievable and Fully-Deployable Stents Accelerate Adoption in Complex Neurovascular Cases
    • Rising Use of Drug-Eluting Stents for Neurovascular Applications Expands Opportunities for Improved Patient Outcomes
    • Expansion of Stent-Assisted Coiling in Aneurysm Procedures Generates New Demand for Hybrid Neurovascular Devices
    • Increasing Focus on Patient-Specific Stents and Customized Solutions Drives Growth in Personalized Neurovascular Interventions
    • Growing Adoption of Bioabsorbable Stents Strengthens Market for Next-Generation Neurovascular Devices
    • Rising Prevalence of Cerebral Aneurysms in Aging Populations Expands Market for Neurovascular Stents in Elderly Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurovascular Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurovascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Carotid Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Intracranial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Intracranial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Intracranial Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Neurovascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Neurovascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Neurovascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Europe 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Rest of Europe 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Asia-Pacific 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Asia-Pacific 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of World 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of World 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION